Flt-1/Fc Chimera, Mouse, Recombinant, Carrier-free <VEGF Receptor 1>

データシート

• 商品コード：471-F1-100
• メーカー：RSD
• 包装：100μg
• 価格： ¥103,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Sugimoto H et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J. Biol. Chem. 2003 Apr;278(15):12605-8
  Sugimoto H et al
  2003/01/01
  
• 備考：
  Application: In Vivo
• 参照：
  

• No.： 2
• 文献情報：
  Gerhardt H et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003 Jun;161(6):1163-77
  Gerhardt H et al
  2003/01/01
  
• 備考：
  Application: In Vivo
• 参照：
  

• No.： 3
• 文献情報：
  Kanda S et al. Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt. J. Biol. Chem. 2004 Feb;279(6):4007-16
  Kanda S et al
  2004/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 4
• 文献情報：
  Gudehithlu KP et al. Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue. J. Lab. Clin. Med. 2005 Apr;145(4):194-203
  Gudehithlu KP et al
  2005/01/01
  
• 備考：
  Application: In Vivo, Sample Type: Whole Tissue
• 参照：
  

• No.： 5
• 文献情報：
  Niida S et al. VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2005 Sep;102(39):14016-21
  Niida S et al
  2005/01/01
  
• 備考：
  Application: In Vivo
• 参照：
  

• No.： 6
• 文献情報：
  Ram鱈rez-Bergeron DL et al. HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Dev. Cell 2006 Jul;11(1):81-92
  Ram鱈rez-Bergeron DL et al
  2006/01/01
  
• 備考：
  Species: Mouse, Application: Bioassay, Sample type: Whole Cells
• 参照：
  

• No.： 7
• 文献情報：
  Cianfarani F et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 2006 Oct;169(4):1167-82
  Cianfarani F et al
  2006/01/01
  
• 備考：
  Application: ELISA Standard
• 参照：
  

• No.： 8
• 文献情報：
  Matsumoto T et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am. J. Pathol. 2006 Oct;169(4):1440-57
  Matsumoto T et al
  2006/01/01
  
• 備考：
  Species: Rat, Application: In Vivo
• 参照：
  

• No.： 9
• 文献情報：
  Ambati BK et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006 Oct;443(7114):993-7
  Ambati BK et al
  2006/01/01
  
• 備考：
  Application: In Vivo, Sample Type: In Vivo
• 参照：
  

• No.： 10
• 文献情報：
  Tsao PN et al. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Crit. Care Med. 2007 Aug;35(8):1955-60
  Tsao PN et al
  2007/01/01
  
• 備考：
  Species: Mouse, Application: In Vivo
• 参照：
  

• No.： 11
• 文献情報：
  Tei K et al. Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis. Stem Cells 2008 Mar;26(3):819-30
  Tei K et al
  2008/01/01
  
• 備考：
  Species: Mouse, Application: In Vivo, In Vivo
• 参照：
  

• No.： 12
• 文献情報：
  Kubota Y et al. Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice. J. Clin. Invest. 2008 Jul;118(7):2393-403
  Kubota Y et al
  2008/01/01
  
• 備考：
  Species: Mouse, Application: In Vivo, In Vivo
• 参照：
  

• No.： 13
• 文献情報：
  Purpura KA et al. Soluble Flt-1 regulates Flk-1 activation to control hematopoietic and endothelial development in an oxygen-responsive manner. Stem Cells 2008 Nov;26(11):2832-42
  Purpura KA et al
  2008/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 14
• 文献情報：
  Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
  Ponticelli S et al
  2008/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Other: Tetrameric 4-23-5 Peptide
• 参照：
  

• No.： 15
• 文献情報：
  Tam Tam KB et al. Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am. J. Hypertens. 2011 Jan;24(1):110-3
  Tam Tam KB et al
  2011/01/01
  
• 備考：
  Application: In Vivo, Sample Type: In Vivo
• 参照：
  

• No.： 16
• 文献情報：
  Fukushima Y et al. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J. Clin. Invest. 2011 May;121(5):1974-85
  Fukushima Y et al
  2011/01/01
  
• 備考：
  Application: In Vivo, Sample Type: In Vivo
• 参照：
  

• No.： 17
• 文献情報：
  Abramovich D et al. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome. Endocrinology 2012 Jul;153(7):3446-56
  Abramovich D et al
  2012/01/01
  
• 備考：
  Application: In Vivo, Sample Type: In Vivo
• 参照：
  

• No.： 18
• 文献情報：
  Liu H et al. Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway. Invest. Ophthalmol. Vis. Sci. 2013 Feb;54(2):918-31
  Liu H et al
  2013/01/01
  
• 備考：
  Application: Intravitreal Injection, Sample Type: Intravitreal Injection
• 参照：
  

• No.： 19
• 文献情報：
  Shaw AK et al. TGF&#x3B2; signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions. PLoS ONE 2015;10(1):e0117908
  Shaw AK et al
  2015/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：